MINERVA SURGICAL INC

2022 Q1 Form 10-K Financial Statement

#000095017022004333 Filed on March 23, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021

Balance Sheet

Concept 2022 Q1 2021 Q4 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $27.90M $40.61M $40.61M
YoY Change 133.93%
Cash & Equivalents $27.90M $40.61M $38.52M
Short-Term Investments
Other Short-Term Assets $100.0K $149.0K $11.42M
YoY Change -58.95% 20.46%
Inventory $16.00M $15.68M $15.68M
Prepaid Expenses $1.238M $1.264M
Receivables $7.150M $7.292M $7.292M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $61.48M $75.00M $75.00M
YoY Change 65.13% 65.13%
LONG-TERM ASSETS
Property, Plant & Equipment $4.817M $4.594M $4.594M
YoY Change 59.51% 59.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $524.0K $524.0K $524.0K
YoY Change -13.25%
Total Long-Term Assets $39.02M $40.09M $40.09M
YoY Change -14.02% -14.02%
TOTAL ASSETS
Total Short-Term Assets $61.48M $75.00M $75.00M
Total Long-Term Assets $39.02M $40.09M $40.09M
Total Assets $100.5M $115.1M $115.1M
YoY Change 25.04% 25.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.061M $3.629M $3.629M
YoY Change 3.51% 3.51%
Accrued Expenses $10.75M $10.66M $13.51M
YoY Change 4.49% 8.68%
Deferred Revenue $281.0K $206.0K
YoY Change -5.94%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $189.0K $189.0K
YoY Change -88.67% -88.67%
Total Short-Term Liabilities $26.47M $22.81M $22.81M
YoY Change -31.44% -31.44%
LONG-TERM LIABILITIES
Long-Term Debt $39.15M $39.09M $39.09M
YoY Change 32.84% -59.12%
Other Long-Term Liabilities $143.0K $9.094M $9.094M
YoY Change -85.26%
Total Long-Term Liabilities $39.15M $39.09M $48.18M
YoY Change 32.84% -69.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.47M $22.81M $22.81M
Total Long-Term Liabilities $39.15M $39.09M $48.18M
Total Liabilities $65.76M $70.99M $70.99M
YoY Change -62.76% -62.76%
SHAREHOLDERS EQUITY
Retained Earnings -$260.5M -$249.6M
YoY Change 9.41%
Common Stock $28.00K $28.00K
YoY Change 2700.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $34.74M $44.10M $44.10M
YoY Change
Total Liabilities & Shareholders Equity $100.5M $115.1M $115.1M
YoY Change 25.04% 25.04%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001452965
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.165
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 utrs Voting Rights Percentage
VotingRightsPercentage
0.6667
CY2021 dei Document Type
DocumentType
10-K
CY2021Q2 dei Entity Public Float
EntityPublicFloat
0
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28822283
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-3422906
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
4255 Burton Dr.
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Clara
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-40919
CY2021 dei Entity Registrant Name
EntityRegistrantName
MINERVA SURGICAL, INC.
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95054
CY2021 dei City Area Code
CityAreaCode
855
CY2021 dei Local Phone Number
LocalPhoneNumber
646-7874
CY2021 dei Security12b Title
Security12bTitle
Common Stock, $ 0.001 par value
CY2021 dei Trading Symbol
TradingSymbol
UTRS
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021 dei Auditor Name
AuditorName
BDO USA, LLP
CY2021 dei Auditor Location
AuditorLocation
San Jose, CA
CY2021 dei Auditor Firm
AuditorFirmId
243
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40608000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17359000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
7283000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
7203000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7292000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8379000
CY2021Q4 us-gaap Inventory Net
InventoryNet
15682000
CY2020Q4 us-gaap Inventory Net
InventoryNet
10201000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4139000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2279000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
75004000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
45421000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
524000
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
604000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
34970000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
43141000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4594000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2880000
CY2021Q4 us-gaap Assets
Assets
115092000
CY2020Q4 us-gaap Assets
Assets
92046000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3629000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3506000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3518000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2889000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10473000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10204000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
5000000
CY2020Q4 utrs Delayed Cash Purchase Consideration
DelayedCashPurchaseConsideration
15000000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
189000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1668000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22809000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
33267000
CY2020Q4 utrs Redeemable Convertible Preferred Stock Warrant Liability Noncurrent
RedeemableConvertiblePreferredStockWarrantLiabilityNoncurrent
42000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
39085000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
29423000
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
0
CY2020Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
46500000
CY2020Q4 utrs Convertible Notes Payables
ConvertibleNotesPayables
66196000
CY2021Q4 utrs Derivative Liability Related To Related Parties
DerivativeLiabilityRelatedToRelatedParties
0
CY2020Q4 utrs Derivative Liability Related To Related Parties
DerivativeLiabilityRelatedToRelatedParties
23600000
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
38007000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
9094000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
23667000
CY2021Q4 us-gaap Liabilities
Liabilities
70988000
CY2020Q4 us-gaap Liabilities
Liabilities
190602000
CY2021Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
0
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
121732397
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
12397838
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
12397838
CY2021Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
0
CY2020Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
136168000
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
123255000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
144406928
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28822283
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21580000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18648000
CY2021 us-gaap Gross Profit
GrossProfit
30523000
CY2020 us-gaap Gross Profit
GrossProfit
19120000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
32193000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
22974000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28822283
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1192299
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1192299
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
28000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
293621000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6269000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
11000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
11000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-249556000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-228092000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
44104000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-221811000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
115092000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
92046000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
52103000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37768000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22183000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8212000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5292000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3324000
CY2021 us-gaap Operating Expenses
OperatingExpenses
59668000
CY2020 us-gaap Operating Expenses
OperatingExpenses
34510000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-29145000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-15390000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
10000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
81000
CY2021 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
4500000
CY2020 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
4600000
CY2021 us-gaap Interest Expense
InterestExpense
11728000
CY2020 us-gaap Interest Expense
InterestExpense
12140000
CY2021 utrs Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
38007000
CY2020 utrs Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
8340000
CY2020 utrs Gain Loss On Bargain Purchase
GainLossOnBargainPurchase
643000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-21295000
CY2021 utrs Gain Loss On Extinguishment Of Payroll Protection Program Loan
GainLossOnExtinguishmentOfPayrollProtectionProgramLoan
3036000
CY2021 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-340000
CY2020 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
71000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-687000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
532000
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1501000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21455000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18395000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-132000
CY2020 utrs Change In Fair Value Of Redeemable Convertible Preferred Stock Warrant Liability
ChangeInFairValueOfRedeemableConvertiblePreferredStockWarrantLiability
33000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-21464000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-18263000
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.06
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-18.85
CY2021 utrs Weighted Average Shares Used In Computing Net Loss Per Share Basic And Diluted
WeightedAverageSharesUsedInComputingNetLossPerShareBasicAndDiluted
7012226
CY2020 utrs Weighted Average Shares Used In Computing Net Loss Per Share Basic And Diluted
WeightedAverageSharesUsedInComputingNetLossPerShareBasicAndDiluted
968648
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-204524000
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
427000
CY2020 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-175000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
118000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
858000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-18263000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-221811000
CY2021 utrs Adjustments To Additional Paid In Capital Conversion Of Convertible Preferred Stock Warrant Into Common Stock Warrants Upon Initial Public Offering
AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantIntoCommonStockWarrantsUponInitialPublicOffering
370000
CY2021 utrs Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities
TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities
123255000
CY2021 utrs Stock Issued During Period Value Convertible Notes In To Common Stock Upon Initial Public Offering
StockIssuedDuringPeriodValueConvertibleNotesInToCommonStockUponInitialPublicOffering
89303000
CY2020 us-gaap Profit Loss
ProfitLoss
-18263000
CY2020 us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
643000
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3348000
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3321000
CY2021 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
5842000
CY2020 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
6955000
CY2021 us-gaap Derivative Fair Value Hedge Included In Effectiveness Gain Loss
DerivativeFairValueHedgeIncludedInEffectivenessGainLoss
38007000
CY2020 us-gaap Derivative Fair Value Hedge Included In Effectiveness Gain Loss
DerivativeFairValueHedgeIncludedInEffectivenessGainLoss
8340000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-132000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1087000
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
8414000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
66585000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
975000
CY2021 utrs Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
74000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6817000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-21464000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
44104000
CY2021 us-gaap Profit Loss
ProfitLoss
-21464000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4432000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9072000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1264000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5025000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1064000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3300000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-21295000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10620000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7076000
CY2021 utrs Gain On Forgiveness Of Pay Check Protection Program Loan
GainOnForgivenessOfPayCheckProtectionProgramLoan
3036000
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
6817000
CY2020 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
858000
CY2021 utrs Change In Fair Value Of Redeemable Convertible Preferred Stock Warrant Liability
ChangeInFairValueOfRedeemableConvertiblePreferredStockWarrantLiability
-328000
CY2021 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
629000
CY2020 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
553000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22379000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12241000
CY2020 us-gaap Payments To Acquire Business Two Net Of Cash Acquired
PaymentsToAcquireBusinessTwoNetOfCashAcquired
15000000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
584000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
453000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-584000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15453000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
975000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
118000
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
39531000
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
17959000
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
69750000
CY2021 utrs Payment Of Delayed Purchase Obligation And Development Milestone
PaymentOfDelayedPurchaseObligationAndDevelopmentMilestone
25000000
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
103000
CY2021 utrs Payment Of Success Fee
PaymentOfSuccessFee
400000
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
35376000
CY2021 utrs Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
3165000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
46212000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18077000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23249000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9617000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25166000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
34783000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
48415000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25166000
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
40608000
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
17359000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
7807000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
7807000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
48415000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25166000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
2318000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
1799000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
18000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
4000
CY2021 utrs Forgiveness Of Ppp Loan
ForgivenessOfPPPLoan
-3036000
CY2021 utrs Conversion Of Series D Redeemable Convertible Preferred Stock Warrants Into Common Stock Warrants Upon Initial Public Offering
ConversionOfSeriesDRedeemableConvertiblePreferredStockWarrantsIntoCommonStockWarrantsUponInitialPublicOffering
370000
CY2021 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
123255000
CY2021 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
89303000
CY2021 utrs Deferred Offering Costs Reclassified To Equity
DeferredOfferingCostsReclassifiedToEquity
3165000
CY2020 utrs Issuance Of Derivative Instruments Related To Convertible Notes
IssuanceOfDerivativeInstrumentsRelatedToConvertibleNotes
6848000
CY2020 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
57222000
CY2020 utrs Fair Value Of Contingent Consideration In Connection To Business Combination
FairValueOfContingentConsiderationInConnectionToBusinessCombination
23842000
CY2020 utrs Fair Value Of Delayed Cash Consideration In Connection To Business Combination
FairValueOfDelayedCashConsiderationInConnectionToBusinessCombination
15000000
CY2020 utrs Issuance Of Series D Redeemable Convertible Preferred Stock In Connection To Business Combination
IssuanceOfSeriesDRedeemableConvertiblePreferredStockInConnectionToBusinessCombination
2737000
CY2021 utrs Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
74000
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6000
CY2021 utrs Net Reclassification Of Inventory To Property And Equipment For Customer Usage Agreements
NetReclassificationOfInventoryToPropertyAndEquipmentForCustomerUsageAgreements
3598000
CY2020 utrs Net Reclassification Of Inventory To Property And Equipment For Customer Usage Agreements
NetReclassificationOfInventoryToPropertyAndEquipmentForCustomerUsageAgreements
1150000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
19404066
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-21500000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-18300000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-249600000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40600000
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentration of credit risk</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash, cash equivalents and accounts receivable. The Company maintains its cash and cash equivalents balances with established financial institutions and, at times, such balances with any one financial institution may be in excess of the Federal Deposit Insurance Corporation (FDIC) insured limits.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company earns revenue from sale of disposable devices and controllers to customers such as hospitals, ACS and physician offices. The Company’s accounts receivable are derived from revenue earned from customers. The Company performs ongoing credit evaluations of its customers’ financial condition and generally requires no collateral from its customers. As of December 31, 2021 and 2020, and for the years then ended, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> customer accounted for more than 10% of accounts receivable or revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
CY2021Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-6.046
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Although these estimates are based on the Company’s knowledge of current events and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Significant estimates and assumptions include accounts receivable allowances, inventory allowances, recoverability of long-term assets, valuation of equity instruments and equity-linked instruments, valuation of common stock, stock-based compensation, valuation of the redeemable convertible preferred stock warrant liability and derivative liabilities, valuation and estimated useful lives of intangible assets, deferred tax assets and related valuation allowances, and impact of contingencies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 utrs Number Of Customer Accounted For Accounts Receivable Or Revenue
NumberOfCustomerAccountedForAccountsReceivableOrRevenue
0
CY2020 utrs Number Of Customer Accounted For Accounts Receivable Or Revenue
NumberOfCustomerAccountedForAccountsReceivableOrRevenue
0
CY2021 utrs Concentration Of Suppliers
ConcentrationOfSuppliers
<span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentration of suppliers</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company purchases certain components of its products from a single or small number of suppliers. A change in or loss of these suppliers could cause a delay in filling customer orders and a possible loss of sales, which could adversely affect results of operations; however, management believes that suitable replacement suppliers could be obtained in such an event.</span></p>
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
7800000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
7800000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
500000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
400000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
300000
CY2021 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
38522000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
38522000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
100000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
200000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
14094000
CY2021Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
14094000
CY2020Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
14638000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
14638000
CY2021 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Product warranties</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company generally offers a one-year warranty for its products. The Company provides for the estimated cost of product warranties at the time product revenue is recognized. Factors that affect the Company’s warranty reserves include the number of units sold, historical and anticipated rates of warranty repairs and the cost per repair. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary. Costs to perform warranty obligations were less than</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million for</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> the years ended December 31, 2021 and 2020.</span></p>
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
38007000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
23667000
CY2021Q4 utrs Expected Operating Lease Right Of Use Assets
ExpectedOperatingLeaseRightOfUseAssets
900000
CY2021Q4 utrs Expected Operating Lease Liability
ExpectedOperatingLeaseLiability
1200000
CY2021 utrs Percentage Of Revenue From Contract With Customer Excluding Assessed Tax
PercentageOfRevenueFromContractWithCustomerExcludingAssessedTax
1
CY2020 utrs Percentage Of Revenue From Contract With Customer Excluding Assessed Tax
PercentageOfRevenueFromContractWithCustomerExcludingAssessedTax
1
CY2021 utrs Percentage Of Revenue Subject To Point In Time Recognition
PercentageOfRevenueSubjectToPointInTimeRecognition
0.990
CY2020 utrs Percentage Of Revenue Subject To Point In Time Recognition
PercentageOfRevenueSubjectToPointInTimeRecognition
0.990
CY2021 utrs Minimum Percentage Of Sale Extended Warranties On Capital Equipment
MinimumPercentageOfSaleExtendedWarrantiesOnCapitalEquipment
0.010
CY2021 utrs Maximum Percentage Of Total Revenue Derived From Sale Of Single Use Disposable Products
MaximumPercentageOfTotalRevenueDerivedFromSaleOfSingleUseDisposableProducts
0.980
CY2021Q4 us-gaap Contract With Customer Receivable Allowance For Credit Loss
ContractWithCustomerReceivableAllowanceForCreditLoss
7292000
CY2020Q4 us-gaap Contract With Customer Receivable Allowance For Credit Loss
ContractWithCustomerReceivableAllowanceForCreditLoss
8379000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
206000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
219000
CY2020Q4 utrs Redeemable Convertible Preferred Stock Warrant Liability
RedeemableConvertiblePreferredStockWarrantLiability
42000
CY2020Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
61716000
CY2020 utrs Fair Value Derivative Liabilities Expected Exit Date
FairValueDerivativeLiabilitiesExpectedExitDate
2022-06-30
CY2021Q4 us-gaap Cash
Cash
2086000
CY2020Q4 us-gaap Cash
Cash
2721000
CY2021Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
38522000
CY2020Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
14638000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40608000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17359000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9495000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5068000
CY2021Q4 utrs Inventory Component Materials
InventoryComponentMaterials
6187000
CY2020Q4 utrs Inventory Component Materials
InventoryComponentMaterials
5133000
CY2021Q4 us-gaap Inventory Net
InventoryNet
15682000
CY2020Q4 us-gaap Inventory Net
InventoryNet
10201000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1264000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1794000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2726000
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
122000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
149000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
363000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4139000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2279000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13911000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10664000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9317000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7784000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4594000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2880000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2400000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2000000.0
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
48264000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13294000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
34970000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
48254000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5113000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
43141000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8200000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5100000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
8182000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5376000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3693000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3693000
CY2021Q4 utrs Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
14016000
CY2021Q4 utrs Finite Lived Future Amortization Of Intangible Assets Net
FiniteLivedFutureAmortizationOfIntangibleAssetsNet
34960000
CY2021Q4 us-gaap Accrued Vacation Current And Noncurrent
AccruedVacationCurrentAndNoncurrent
1469000
CY2020Q4 us-gaap Accrued Vacation Current And Noncurrent
AccruedVacationCurrentAndNoncurrent
1184000
CY2021Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
1307000
CY2020Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
831000
CY2021Q4 utrs Accrued Commissions Current And Noncurrent
AccruedCommissionsCurrentAndNoncurrent
665000
CY2020Q4 utrs Accrued Commissions Current And Noncurrent
AccruedCommissionsCurrentAndNoncurrent
828000
CY2021Q4 utrs Other Accrued Personnel Related Expenses
OtherAccruedPersonnelRelatedExpenses
77000
CY2020Q4 utrs Other Accrued Personnel Related Expenses
OtherAccruedPersonnelRelatedExpenses
46000
CY2021Q4 utrs Accrued Compensation
AccruedCompensation
3518000
CY2020Q4 utrs Accrued Compensation
AccruedCompensation
2889000
CY2021Q4 utrs Accrued Litigation
AccruedLitigation
7203000
CY2020Q4 utrs Accrued Litigation
AccruedLitigation
7203000
CY2021Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
974000
CY2020Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
824000
CY2021Q4 utrs Accrued Sales And Use Taxes
AccruedSalesAndUseTaxes
657000
CY2020Q4 utrs Accrued Sales And Use Taxes
AccruedSalesAndUseTaxes
754000
CY2021Q4 utrs Accrued Deferred Rent
AccruedDeferredRent
277000
CY2020Q4 utrs Accrued Deferred Rent
AccruedDeferredRent
445000
CY2021Q4 utrs Accrual For Inventory In Transit
AccrualForInventoryInTransit
119000
CY2020Q4 utrs Accrual For Inventory In Transit
AccrualForInventoryInTransit
602000
CY2021Q4 utrs Accrued Contract Liability
AccruedContractLiability
206000
CY2020Q4 utrs Accrued Contract Liability
AccruedContractLiability
219000
CY2021Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
1037000
CY2020Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
157000
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
10473000
CY2020Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
10204000
CY2020 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
44700000
CY2020 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
17300000
utrs Business Acquisition Pro Forma Amortization Of Intangible Assets
BusinessAcquisitionProFormaAmortizationOfIntangibleAssets
3100000
CY2020Q2 utrs Business Combination Changes In Transaction Costs
BusinessCombinationChangesInTransactionCosts
-1000000.0
CY2021Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
19404066
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1300000
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1400000
CY2021 utrs Operating Non Cancellable Lease Terminate Year
OperatingNonCancellableLeaseTerminateYear
2023
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
846000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
358000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1204000
CY2021 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
700000
CY2020 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1100000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-100000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0499
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0334
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.0361
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.0077
CY2021 utrs Effective Income Tax Rate Reconciliation Gain Loss On Debt Extinguishment
EffectiveIncomeTaxRateReconciliationGainLossOnDebtExtinguishment
-0.0853
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.0047
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.0013
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.6241
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2548
CY2021 utrs Effective Income Tax Rate Reconciliation Convertible Debt Embedded Derivative
EffectiveIncomeTaxRateReconciliationConvertibleDebtEmbeddedDerivative
0.4495
CY2020 utrs Effective Income Tax Rate Reconciliation Convertible Debt Embedded Derivative
EffectiveIncomeTaxRateReconciliationConvertibleDebtEmbeddedDerivative
0.0194
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0402
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0082
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0006
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0072
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
50494000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
44568000
CY2021Q4 utrs Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
4656000
CY2020Q4 utrs Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
3375000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
3577000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
2666000
CY2021Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
2229000
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
2250000
CY2020Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
2197000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
63206000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
52806000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
63206000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
49817000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2989000
CY2020Q4 us-gaap Deferred Tax Liabilities Derivatives
DeferredTaxLiabilitiesDerivatives
2989000
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
13400000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
500000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
447000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
431000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
18000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
16000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
465000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
447000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4700000
CY2021 utrs Operating Loss Carryforwards Expiration Beginning Year
OperatingLossCarryforwardsExpirationBeginningYear
2028
CY2021 utrs Income Taxes Rolling Year
IncomeTaxesRollingYear
P3Y
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
12397838
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
121732397
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
12397838
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
12397838
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
123255000
CY2020Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
136168000
CY2021 utrs Temporary Equity Dividends Declared To Date
TemporaryEquityDividendsDeclaredToDate
0
CY2020 utrs Number Of Board Of Director
NumberOfBoardOfDirector
10
CY2021 us-gaap Common Stock Voting Rights
CommonStockVotingRights
The holders of Common Stock, voting as a separate class, shall be entitled to elect three members of the Company’s Board of Directors.
CY2020 utrs Number Of Voting Rights
NumberOfVotingRights
3
CY2021 utrs Temporary Equity Conversion Description
TemporaryEquityConversionDescription
Each share of redeemable convertible preferred stock shall automatically be converted into fully-paid, non-assessable shares of common stock at the then effective conversion rate at the time in effect for such share immediately upon the earlier of (i) the Company’s sale of its common stock in a firm commitment underwritten public offering (public offering price of which is not less than $5.61 per share as adjusted for recapitalization, stock combinations, stock dividends, stock splits and the like) and which results in aggregate cash proceeds to the Company of at least $50,000,000 (before underwriting discounts, commissions, and fees), or (ii) upon the receipt by the Company of a written request for such conversion from the holders of at least 66 2/3% of the redeemable convertible preferred stock then outstanding voting as a single class and on an as-converted basis, or, if later, the effective date for conversion specified in such requests.
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
144406928
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 utrs Warrants To Purchase Redeemable Convertible Preferred Stock
WarrantsToPurchaseRedeemableConvertiblePreferredStock
77842
CY2021Q4 utrs Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
77842
CY2021Q4 utrs Common Stock Options Issued And Outstanding
CommonStockOptionsIssuedAndOutstanding
2175685
CY2020Q4 utrs Common Stock Options Issued And Outstanding
CommonStockOptionsIssuedAndOutstanding
2466594
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1934095
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
67065
CY2021Q4 utrs Restricted Stock Units Issued And Outstanding
RestrictedStockUnitsIssuedAndOutstanding
394750
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2482957
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.96
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7M2D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2257000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
451689
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.61
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
282813
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.73
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.61
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
161366
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.28
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2175685
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.18
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.37
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
8900000
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M6D
CY2021 utrs Repurchase Of Common Stock
RepurchaseOfCommonStock
0
CY2020 utrs Repurchase Of Common Stock
RepurchaseOfCommonStock
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
185239
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.28
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2466594
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.61
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y2M15D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1846375
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.05
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1975918
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.27
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y8M4D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2856000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1502978
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.32
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y4M24D
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2066000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2175685
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
9.27
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y8M4D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
2856000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1800000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
6000000.0
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
600000
CY2021 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
377709
CY2020 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
136032
CY2021 utrs Share Based Compensation Arrangements By Share Based Payment Award Options Aggregate Exercise Prices Of Early Exercised Shares
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAggregateExercisePricesOfEarlyExercisedShares
200000
CY2020 utrs Share Based Compensation Arrangements By Share Based Payment Award Options Aggregate Exercise Prices Of Early Exercised Shares
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAggregateExercisePricesOfEarlyExercisedShares
100000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6817000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
858000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6817000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
858000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.728
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.780
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.616
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.752
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.006
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.013
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.003
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.007
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-21464000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-18263000
CY2021 utrs Weighted Average Shares Used In Computing Net Loss Per Share Basic And Diluted
WeightedAverageSharesUsedInComputingNetLossPerShareBasicAndDiluted
7012226
CY2020 utrs Weighted Average Shares Used In Computing Net Loss Per Share Basic And Diluted
WeightedAverageSharesUsedInComputingNetLossPerShareBasicAndDiluted
968648
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.06
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-18.85
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0

Files In Submission

Name View Source Status
0000950170-22-004333-index-headers.html Edgar Link pending
0000950170-22-004333-index.html Edgar Link pending
0000950170-22-004333.txt Edgar Link pending
0000950170-22-004333-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img109022409_0.jpg Edgar Link pending
img109022409_1.jpg Edgar Link pending
img109022409_10.jpg Edgar Link pending
img109022409_2.jpg Edgar Link pending
img109022409_3.jpg Edgar Link pending
img109022409_4.jpg Edgar Link pending
img109022409_5.jpg Edgar Link pending
img109022409_6.jpg Edgar Link pending
img109022409_7.jpg Edgar Link pending
img109022409_8.jpg Edgar Link pending
img109022409_9.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
utrs-20211231.htm Edgar Link pending
utrs-20211231.xsd Edgar Link pending
utrs-20211231_cal.xml Edgar Link unprocessable
utrs-20211231_def.xml Edgar Link unprocessable
utrs-20211231_htm.xml Edgar Link completed
utrs-20211231_lab.xml Edgar Link unprocessable
utrs-20211231_pre.xml Edgar Link unprocessable
utrs-ex23_1.htm Edgar Link pending
utrs-ex31_1.htm Edgar Link pending
utrs-ex31_2.htm Edgar Link pending
utrs-ex32_1.htm Edgar Link pending
utrs-ex32_2.htm Edgar Link pending
utrs-ex4_6.htm Edgar Link pending